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Abstract
Personality disorders (PDs) are pervasive and affect patients with psychiatric illnesses. While difficult to treat
with pharmacotherapy, compared to Axis I disorders(e.g. depression, schizophrenia), Axis II disorders may
impact the manner in which patients are clinically approached. It may behoove faculty teaching
psychopharmacotherapy to integrate PDs into their teaching. Prior work by Cates et al. showed personality
disorders are not commonly discussed in pharmacy curricula. As a clinician with experience in psychiatric
pharmacy, I felt knowledge of PDs was crucial to my practice and enriched my interactions with patients and
professionals. As a professor of psychopharmacotherapy, I integrated PDs into every lecture using active
learning methods (e.g. case-based vignettes, student reflection papers). I feel our students benefitted from this
integration. This study will present specialists’ perceptions regarding the useof PD knowledge in practice and/
or teaching. Results will help determine if PDs should be a greater part of didactic, pre-APPE Doctor of
Pharmacy education.
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Introduction
Personality disorders (PDs) are pervasive and affect patients with psychiatric 
illnesses. While difficult to treat with pharmacotherapy, compared to Axis I 
disorders (e.g. depression, schizophrenia), Axis II disorders may impact the manner 
in which patients are clinically approached. It may behoove faculty teaching 
psychopharmacotherapy to integrate PDs into their teaching. Prior work by Cates 
et al. showed personality disorders are not commonly discussed in pharmacy 
curricula. As a clinician with experience in psychiatric pharmacy, I felt knowledge 
of PDs was crucial to my practice and enriched my interactions with patients and 
professionals. As a professor of psychopharmacotherapy, I integrated PDs into 
every lecture using active learning methods (e.g. case-based vignettes, student 
reflection papers). I feel our students benefitted from this integration. This study 
will present specialists’ perceptions regarding the use of PD knowledge in practice 
and/or teaching. Results will help determine if PDs should be a greater part of 
didactic, pre-APPE Doctor of Pharmacy education.
Methods
College of Psychiatric and Neurological Pharmacy specialists (n = 374) were
approached with an online request communicated via email to participate in a
voluntary 10-item survey asking for the following: 
PollDaddy.com, a third party online service, was used to execute the survey and 
the project was approved by our institutional review board.
The following objectives were targeted: 
1. Describe specialty pharmacists’ practice settings, general location, experience 
and training, and, years of service to the profession
2. Inventory practitioners’ and educators’ familiarity with, and exposure to, 
personality disorders
3. Identify practitioners’ and educators’ perceptions regarding the importance of 
personality disorders in teaching and practice 
Descriptive statistics are used to communicate the resulting trends and outcomes.
Results
•Respondents (n = 92) out of 374 answered all survey items. 
•Approximately 82% of respondents agreed that PDs should be taught to 
pharmacy students in pre-clinical and didactic Pharm.D. education before 
students enter APPE.  
•About 77%, 88% and 58% of all respondents reported knowledge of PDs 
increased their effectiveness as clinicians, proved generally useful in their 
practice areas, and piqued their interest in psychopharmacotherapy, 
respectively. The most common PD encountered was borderline. 
Discussion
•A majority of respondents agreed that PDs should be taught in didactic and 
pre-clinical Pharm.D. curricula. 
• Clinical preceptors not appointed to roles in academia (80.5%) were more 
likely than clinical preceptors affiliated with the academy (64.9%) or full-time 
faculty members (65.8%) to agree these disorders should be taught prior to 
APPE. Differences may be due to faculty members’ recognition of real and 
perceived barriers in the implementation of changes to Pharm.D. curricula. 
• The majority of pharmacists in every role ranging from dispensing at out-
patient settings (93.3%) to actively working in inter-professional teams in the 
acute psychiatric clinics (78.8%) reported that PDs should be part of didactic 
Pharm.D. curricula. Pharmacists monitoring patient outcomes (80.6%), guiding 
formulary options (85.2%), interviewing patients (82.2%), documenting care 
(85%), prescribing medications (87.1%), and working with others in quality 
improvement endeavors for their institutions (92.1%) were in agreement. 
•The widespread support of integrating PDs correlates with reported greater 
effectiveness when approaching patients (77.2%). Perhaps greater levels of 
interactions with patients and diverse providers creates a better appreciation of 
PD concepts, knowledge and applications. 
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Conclusions
•It may behoove faculty teaching psychopharmacy to integrate content 
highlighting the most commonly encountered PDs. 
•Borderline disorders, or more broadly, Cluster B disorders may help students 
effectively interact with those suffering from mental illness. 
•Further work may in this area may ask practitioners and educators to explain 
specifically why PDs should or should not be added to didactic curricula.   
•Regarding applicability, greater exposure to PDs may add to pharmacists’ 
effective interviewing and approaches to adherence in difficult populations. 
Question Item
1 Describing Practice Area: Please provide information on all areas of practice with which you 
are involved. 
2 Degrees and Certifications: Please provide information on your current degrees and 
certifications.
3 Training: Please provide information on your post-Pharmacy graduate training in psychiatry / 
clinical pharmacy.
4 Practice Timeline: Please provide information on your post-training years in practice. Which
description BEST describes your time spent as a practitioner? 
5 Which of the following describe your perceptions of personality (or cluster) disorders?
6 Practice Duties: Please provide information on activities carried out in your day-to-day 
operations as a practitioner.
7 Personality Disorder Inventory: Please check all of the personality disorders with which you 
are familiar.
8 As a practitioner or professor, do you think students should be taught about the concepts 
related to personality disorders during their didactic Pharm.D. curriculum? 
9 Please state the SINGLE MOST COMMON personality disorder you encounter in your practice 
on a regular basis. 
10 Geographic location: Where is your practice or teaching institution generally located?
Description of specialty pharmacists’ practice roles settings, 
education, training and years of service to the profession
Describing the Roles of the Psychiatric Pharmacy Specialist
Pharmacists with multiple roles within their organizations. 56.5%
Pharmacist educators / professors in Pharm.D. curricula 47.8%
Pharmacists with interprofessional care roles and responsibilities 63.0%
Pharmacists with community-focused and patient consultative roles 23.9%
Pharmacists with diverse consultant roles in patient care  21.7%
Pharmacists with prescriptive care roles and responsibilities 30.4%
Describing Psychiatric Pharmacy Specialists’ Training
Pharmacists/Psychiatric specialists without a Pharm.D. 38.0%
Pharmacists/Psychiatric specialists with a Pharm.D. 86.9%
Pharmacists possessing an undergraduate or graduate psychology degree 8.7%
Pharmacists/Psychiatric specialists certified as geriatric pharmacists (CGP) 11.9%
Pha macists/Psychiatric specialists certified in psychopharmacy (BCPP)  78.2%
Pharmacists providing no response to training 25.0%
Pharmacists completing a PGY-1 / Pharmacy Practice Residency 29.3%
Pharmacists completing a PGY-2 Non-psychiatry / Non-psych Specialty 6.5%
Pharmacists completing a PGY-2 Psychiatry / Specialty Psychopharmacy 45.6%
Pharmacists completing Fellowship training after 1 (or more) residencies  21.7%
Describing the Psychiatric Pharmacy Specialists’ Years of Service to the Profession
Pharmacists practicing at least 10 ye rs 25.0%
Pharmacists practicing at least 20 years 25.0%
Pharmacists practicing at least 30 years 10.7%
Pharmacists practicing < 10 years 39.1%
Description of specialty pharmacists’ exposure to, and familiarity with, various personality disorders 
The Personality Disorder Inventory
Personality Disorder Practitioner’s Familiarity
with this Disorder
Disorders Reported
to be Encountered
Antisocial 96.7% 3.3%
Avoidant 68.5% 0%
Borderline 98.9% 77.2%
Dependent 88.0% 0%
Histrionic 85.9% 2.2%
Narcissistic 94.6% 2.2%
OCPD 94.6% 0%
Paranoid 88.0% 1.1%
Schizoid 78.3% 0%
Schizotypal 76.1% 0%
